Chemical and Pharmaceutical Bulletin p. 1858 - 1864 (1996)
Update date:2022-08-05
Topics:
Take, Kazuhiko
Okumura, Kazuo
Tsubaki, Kazunori
Taniguchi, Kiyoshi
Terai, Takao
Shiokawa, Youichi
N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine ((±)-3) was designed to restrict the conformation of terodiline I and was synthesized in a 6-step approach starting with diphenylacetaldehyde (10) or in a 4-step approach starting with 2,2-diphenyl-4-pentenoi
View MoreLianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
Lyrin Industrial Corporation Limited
Contact:86-731-82571800
Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Beijing Green Guardee Technology CO,.LTD
Contact:+86-10-69706062
Address:F2 BLdj,5 No.37 Chaoqian Road
Shanghai HengXun Pharmaceutical Tech. Co., Ltd.
Contact:86-86-52730756
Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
Doi:10.1039/a806200e
(1998)Doi:10.1021/jo00926a009
(1974)Doi:10.1021/jo00926a028
(1974)Doi:10.1246/bcsj.50.3417
(1977)Doi:10.1021/jo00322a047
(1981)Doi:10.1016/S0022-328X(00)86537-7
(1973)
